News
The Independent on MSN49m
Mounjaro is available on the NHS. Here’s what to do if you’re not eligibleMounjaro is available on the NHS. Here’s what to do if you’re not eligible - Mounjaro has been approved for both type 2 ...
HealthDay on MSN53m
Studies Address Muscle Loss Caused By GLP-1 DrugsKey Takeaways A new drug combo can help prevent muscle loss on GLP-1 drugsCombining bimagrumab with semaglutide caused 93% of weight loss to come from fat aloneBy comparison, about 72% of weight loss ...
Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback